Author

Frank Stout

Observed name: F. Stout

Institution: Apellis Pharmaceuticals (United States)

Observed institution: Apellis Pharmaceuticals (United States)

OpenAlex ID: A5065416340

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

2018 · Federico Grossi, Merrill Kingman Shum, et al. · Blood · 26

S899 Inhibition of C3 With Apl‐2 Controls Haemolysis and Increases Haemoglobin Levels in Subjects With Autoimmune Haemolytic Anaemia (aiha)

2019 · M. Gertz, E. Roman, et al. · HemaSphere · 13

Works count: 2

Citation count: 39

H-index: 2

I10-index: 2